Am J Transplant, Volume 18, Suppl 3 Archives - Page 8 of 211 - ATC Abstracts

2018 American Transplant Congress
The Combination of pAMR and Circulating Donor-Specific Antibodies is Even More Associated with Cardiac Allograft Vasculopathy after Heart Transplant
J. Patel, M. Kittleson, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Cedars Sinai Medical Center, Los Angeles.
Purpose: Several reports have correlated the development of donor-specific antibody (DSA) to the development of cardiac allograft vasculopathy (CAV) after heart transplantation (HTx). Interestingly, patients…
2018 American Transplant Congress
Air Pollution Can Support the Development of Cardiac Allograft Vasculopathy
C. Bara,¹ M. Barten,² D. Boethig,¹ Y. Scheibner,¹ J. Tauber,² H. Reichenspurner,² A. Haverich.¹
¹Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany; ²Cardiovascular Surgery, University Heart Center, Hamburg, Germany.
Purpose:Cardiac allograft vasculopathy (CAV) remains one of most important factors leading to graft dysfunction and mortality after heart transplantation (HTx). Thus, the identification of risk…
2018 American Transplant Congress
Decreased Post Heart Transplant Survival with Epstein-Barr Virus Mismatch in the Current Era
M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, S. Mersola, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Cedars Sinai Medical Center, Los Angeles.
Purpose: Epstein-Barr virus (EBV) has been implicated in a multitude of cancers, including B-cell lymphoma, Burkitt's lymphoma, CNS lymphoma, gastric cancer and nasopharyngeal carcinoma. Previous…
2018 American Transplant Congress
Quantification of the Indirect Effect of Recipient Characteristics on Kidney Graft Function
S. Rao,¹ A. Gillespie,¹ J. Lee,¹ K. Lau,² S. Karhadkar,² A. Di Carlo,² S. Constantinescu.¹
¹Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA; ²Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, PA.
Recipient characteristics play an important role for donor selection in deceased donor kidney transplant recipients (DDKT). The current kidney allocation system (KAS) for deceased donors…
2018 American Transplant Congress
Two Decades of Eurotransplant Senior Program (ESP): Time on Dialysis Independently Impacts Patient Survival, Allograft Survival and Quality of Life after Kidney Transplantation
T. Schachtner,^1,2,3 N. Otto,¹ P. Reinke.^1,2
¹Nephrology and Internal Intensive Care, Charite Campus Virchow Clinic, Berlin, Germany; ²Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charite Campus Virchow Clinic, Berlin, Germany; ³Berlin Institute of Health (BIH), Charite and Max Delbrueck Center, Berlin, Germany.
In 1999, the Eurotransplant Senior Program (ESP) was implemented and allocates kidneys from deceased-donors ≥65 years to kidney transplant recipients ≥65 years (ESP-KTRs). The ESP…
2018 American Transplant Congress
Greater Access to Kidney Transplantation in Competitive DSAs: Due to Improved Referral?
J. Adler,¹ D. Chang,² H. Yeh.²
¹Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI; ²Surgery, Massachusetts General Hospital, Boston, MA.
INTRODUCTION: For patients with chronic kidney disease (CKD), access to kidney transplantation (ATT) varies across the 58 Donor Service Areas (DSAs) of the United States,…
2018 American Transplant Congress
The Efficacy and Safety of Rituximab as Induction Therapy in Kidney Transplantation: A Meta-Analysis of Randomized Controlled Trials
X. Wang,¹ J. Chen,² X. Tu,² Y. Qiu,¹ T. Song,¹ T. Lin.¹
¹Department of Urology/Institute of Urology/Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China; ²West China School of Clinical Medicine, Sichuan University, Chengdu, Sichuan Province, China.
Objectives. This meta-analysis was undertaken to assess the efficacy and safety of rituximab as induction therapy in kidney transplantation.Methods. OVID, Embase, SCI, PubMed and EBSCO…
2018 American Transplant Congress
Thymoglobulin Dose and Effect on Short-Term Kidney Transplant Outcomes
P. Sood, W. Christine, R. Mehta, A. Tevar, C. Puttarajappa, K. Schonder, K. Shimko, S. Hariharan.
University of Pitstburgh Medical Center, Pittsburgh.
Thymoglobulin is a commonly used induction agent for kidney transplantation. Optimal dosing for thymoglobulin is not well defined, and weight based dosing is often used.…
2018 American Transplant Congress
Delayed Recovery of Renal Function after Donor Nephrectomy
J. Na,¹ J. Park,¹ M-.G. Yoon,¹ H. Lee,² Y. Yoon,³ K. Huh,⁴ M. Kim,⁴ S. Kim,⁴ Y. Kim,⁴ W. Han.¹
¹Department of Urology, Yonsei University College of Medicine, Urological Science Institute, Seoul, Korea; ²Department of Urology, National Health Insurance Service Ilsan Hospital, Goyang-si, Korea; ³Department of Urology, Hanyang University Medical Center, Seoul, Korea; ⁴Department of Surgery-Transplantation, Yonsei University College of Medicine, Seoul, Korea.
Introduction:Among living kidney donors at risk of CKD at 1 year after nephrectomy, some donors remain with poor renal function while many show delayed recovery…
2018 American Transplant Congress
Effect of Functional and Cognitive Impairment on Readmissions in Geriatric Renal Transplant Recipients
T. Uemura,¹ V. Rodriguez,¹ G. Rosen,² S. Lerner,² O. Apoeso.¹
¹Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, NY; ²Recanati/Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Background:Renal transplantationhas become increasingly more prevalent in geriatric populations. To optimize outcomes, renal transplant patients must be compliant with post-operative medication useand clinic follow up.…

« Previous Page
1
…
6
7
8
9
10
…
211
Next Page »